biological source
goat
antibody form
purified antibody
antibody product type
primary antibodies
clone
polyclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable, immunofluorescence: suitable, immunohistochemistry: suitable, western blot: suitable
shipped in
wet ice
Quality Level
Immunogen
来自5型腺病毒的六邻体。
Application
ELISA：>1:5,000
间接荧光显微镜检查。
免疫印迹：仅1 mM DTT和2%SDS中的未煮沸样品
免疫组化
最佳工作稀释度必须由最终用户进行确定
间接荧光显微镜检查。
免疫印迹：仅1 mM DTT和2%SDS中的未煮沸样品
免疫组化
最佳工作稀释度必须由最终用户进行确定
研究子类别
传染病 - 病毒
传染病 - 病毒
研究类别
传染病
传染病
该抗腺病毒抗体经验证可用于ELISA、IF、WB、IH检测腺病毒。
Biochem/physiol Actions
腺病毒，六邻体组装。与Para 1-3、流行性感冒A & B或RSV无交叉反应。与HEp-2细胞无反应。
Physical form
IgG部分（纯度>95%）。 在PBS（0.01 M，pH 7.2）中，含0.1%叠氮化钠
形式：纯化
Preparation Note
自收到之日起，在-20°下以未稀释的等分试样可保存12个月。应避免反复冻/融循环。
Other Notes
浓度：请参考批次特异性浓缩物的检验报告。
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
未找到合适的产品？
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Matthew Glen Robertson et al.
Molecular therapy oncolytics, 20, 659-668 (2021-04-06)
Encoding the sodium iodide symporter (NIS) by an adenovirus (Ad) is a promising strategy to facilitate non-invasive imaging and radiotherapy of pancreatic cancer. However, insufficient levels of NIS expression in tumor cells have limited its clinical translation. To optimize Ad-based
Highly efficient and carcinoma-specific adenoviral replication restricted by the EGP-2 promoter.
W M Gommans, P M J McLaughlin, J A C Schalk, G M M Groothuis, H J Haisma, M G Rots
Journal of Controlled Release : Official Journal of the Controlled Release Society null
M Verónica Lopez et al.
PloS one, 4(4), e5119-e5119 (2009-04-02)
The clinical efficacy of conditionally replicative oncolytic adenoviruses (CRAd) is still limited by the inefficient infection of the tumor mass. Since tumor growth is essentially the result of a continuous cross-talk between malignant and tumor-associated stromal cells, targeting both cell
Frederick F Lang et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 36(14), 1419-1427 (2018-02-13)
Purpose DNX-2401 (Delta-24-RGD; tasadenoturev) is a tumor-selective, replication-competent oncolytic adenovirus. Preclinical studies demonstrated antiglioma efficacy, but the effects and mechanisms of action have not been evaluated in patients. Methods A phase I, dose-escalation, biologic-end-point clinical trial of DNX-2401 was conducted
Isolated limb perfusion: a novel delivery system for wild-type p53 and fiber-modified oncolytic adenoviruses to extremity sarcoma.
Hannay, J; Davis, JJ; Yu, D; Liu, J; Fang, B; Pollock, RE; Lev, D
Gene Therapy null
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持